INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2010

After 33 years and at least 1,591 patients, it remains unknown whether vitamin C has clinically significant antitumor activity.

This review evaluates 33 years of clinical trials involving at least 1,591 cancer patients treated with vitamin C. A 1976 study reporting that 100 terminal cancer patients given intravenous and oral vitamin C lived four times longer than 1,000 controls was strongly criticized for major control group imbalances that artificially extended survival. Subsequent trials, including three double-blind placebo-controlled randomized trials of oral vitamin C at the Mayo Clinic, were negative, and a phase I-II trial of intravenous vitamin C found zero responses in 24 patients. The authors conclude it is still unknown whether vitamin C has any clinically significant antitumor activity, which cancer types might be susceptible, or what dose might produce a therapeutic response.

Study type
Narrative review
Who was studied
At least 1,591 cancer patients across 33 years of trials
What was measured
Survival, tumor shrinkage, and antitumor response

THE PAPER

Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?

Cabanillas F. P R Health Sci J, 2010.

PubMed 20799507 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.